Champions Oncology Inc.

9.03
0.42 (4.88%)
At close: Apr 02, 2025, 3:59 PM
8.66
-4.05%
After-hours: Apr 02, 2025, 04:09 PM EDT

Champions Oncology Statistics

Share Statistics

Champions Oncology has 13.83M shares outstanding. The number of shares has increased by 1.71% in one year.

Shares Outstanding 13.83M
Shares Change (YoY) 1.71%
Shares Change (QoQ) 0.06%
Owned by Institutions (%) 42.07%
Shares Floating 6.11M
Failed to Deliver (FTD) Shares 501
FTD / Avg. Volume 1.03%

Short Selling Information

The latest short interest is 217.88K, so 1.58% of the outstanding shares have been sold short.

Short Interest 217.88K
Short % of Shares Out 1.58%
Short % of Float 3.57%
Short Ratio (days to cover) 20.86

Valuation Ratios

The PE ratio is -9.03 and the forward PE ratio is 44.71. Champions Oncology's PEG ratio is -0.23.

PE Ratio -9.03
Forward PE 44.71
PS Ratio 1.31
Forward PS 1.7
PB Ratio -34.53
P/FCF Ratio -9.42
PEG Ratio -0.23
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Champions Oncology.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.63, with a Debt / Equity ratio of -3.9.

Current Ratio 0.63
Quick Ratio 0.63
Debt / Equity -3.9
Debt / EBITDA -1.47
Debt / FCF -1.07
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $238.83K
Profits Per Employee $-34.65K
Employee Count 210
Asset Turnover 1.92
Inventory Turnover n/a

Taxes

Income Tax -32K
Effective Tax Rate 0.44%

Stock Price Statistics

The stock price has increased by 70.81% in the last 52 weeks. The beta is 0.2, so Champions Oncology's price volatility has been higher than the market average.

Beta 0.2
52-Week Price Change 70.81%
50-Day Moving Average 10.23
200-Day Moving Average 6.46
Relative Strength Index (RSI) 39.31
Average Volume (20 Days) 48.47K

Income Statement

In the last 12 months, Champions Oncology had revenue of 50.16M and earned -7.28M in profits. Earnings per share was -0.54.

Revenue 50.16M
Gross Profit 20.75M
Operating Income -7.36M
Net Income -7.28M
EBITDA -5.05M
EBIT -6.92M
Earnings Per Share (EPS) -0.54
Full Income Statement

Balance Sheet

The company has 2.62M in cash and 7.43M in debt, giving a net cash position of -4.81M.

Cash & Cash Equivalents 2.62M
Total Debt 7.43M
Net Cash -4.81M
Retained Earnings -84.59M
Total Assets 30.63M
Working Capital -173K
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -6.14M and capital expenditures -836K, giving a free cash flow of -6.97M.

Operating Cash Flow -6.14M
Capital Expenditures -836K
Free Cash Flow -6.97M
FCF Per Share -0.51
Full Cash Flow Statement

Margins

Gross margin is 41.38%, with operating and profit margins of -14.67% and -14.51%.

Gross Margin 41.38%
Operating Margin -14.67%
Pretax Margin -14.57%
Profit Margin -14.51%
EBITDA Margin -10.08%
EBIT Margin -14.67%
FCF Margin -13.9%

Dividends & Yields

CSBR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CSBR is $12, which is 38.6% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12
Price Target Difference 38.6%
Analyst Consensus Strong Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Aug 12, 2015. It was a backward split with a ratio of 1:12.

Last Split Date Aug 12, 2015
Split Type backward
Split Ratio 1:12

Scores

Altman Z-Score 5.47
Piotroski F-Score 5